Loading and in vitro release of ibuprofen in tubular halloysite
Source abstract
Abstract
Abstract Halloysite (Hal) and 3-aminopropyltriethoxysilane (APTES)-modified Hal were used as drug carriers for the loading and release of ibuprofen (IBU). IBU exhibited a low loading capacity and a fast release in unmodified Hal because of the weak interaction (hydrogen bonds) between IBU and the unmodified halloysite. APTES modification increased the loading capacity of IBU and slowed the release of IBU by introducing a strong affinity through electrostatic attraction, which was generated between the carboxyl groups of IBU and the introduced aminopropyl groups of the grafted APTES. The release profiles of IBU were well fitted with the modified Korsmeyer–Peppas model. The release mechanism of IBU from unmodified and APTES-modified Hal, indicated by the exponent of the modified Korsmeyer–Peppas model, was Fickian diffusion and non-Fickian diffusion, respectively.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Clay minerals and soil interactions · Soil and Unsaturated Flow · Therapeutic Uses of Natural Elements
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. Clay nanotubes for corrosion inhibitor encapsulation: release control with end stoppers10.1039/c0jm00810a ↗
2. Use of clays as drug delivery systems: possibilities and limitations10.1016/j.clay.2006.06.015 ↗
3. Morphology and structure of endellite and halloysite
4. Molecular motions in amorphous ibuprofen as studied by broadband dielectric spectroscopy10.1021/jp8040428 ↗
5. X-ray studies of halloysite and metahalloysite. 3. The effect of temperature and pressure on the halloysite–metahalloysite transition
6. Pharmacokinetics and bioinversion of ibuprofen enantiomers in humans10.1023/A:1018969506143 ↗
7. Modeling and comparison of dissolution profiles10.1016/S0928-0987(01)00095-1 ↗
8. Development of a dialysis in vitro release method for biodegradable microspheres10.1208/pt060242 ↗
9. A ceramic drug delivery vehicle for oral administration of highly potent opioids10.1002/jps.21814 ↗
10. Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms10.1002/jps.2600561005 ↗
11. Gupta · 2006
12. Novel polyamide nanocomposites based on silicate nanotubes of the mineral halloysite10.1016/j.compscitech.2008.10.011 ↗
13. Rate of release of medicaments from ointment bases containing drugs in suspension10.1002/jps.2600501018 ↗
14. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices10.1002/jps.2600521210 ↗
15. Halloysite clay minerals—a review10.1180/0009855054040180 ↗
16. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis10.1016/j.ijpharm.2004.01.019 ↗
17. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics10.1021/js960307p ↗
18. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
19. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride10.1016/S0378-5173(02)00702-0 ↗
20. Studies on MCM-41 mesoporous silica for drug delivery: Effect of particle morphology and amine functionalization10.1016/j.cej.2007.07.078 ↗
21. Mathematical comparison of dissolution profiles
22. MCM-41 organic modification as drug delivery rate regulator10.1021/cm021217q ↗
23. Characterisation of properties of various halloysites relevant to their use as nanotubes and microfibre fillers10.1016/j.clay.2012.06.014 ↗
24. Analysis of Fickian and non-Fickian drug release from polymers
25. In-vitro release characteristics of tetracycline HCl, khellin and nicotinamide adenine dineculeotide from halloysite: a cylindrical mineral10.1080/02652040010019532 ↗
26. Ibuprofen: pharmacology, efficacy and safety10.1007/s10787-009-0016-x ↗
27. In vitro dissolution profile comparison—statistics and analysis of the similarity factor, f210.1023/A:1011976615750 ↗
28. Halloysite nanotubes as biomimetic nanoreactors10.1002/smll.200400120 ↗
29. Functionalized halloysite nanotube-based carrier for intracellular delivery of antisense oligonucleotides10.1186/1556-276X-6-608 ↗
30. Experimental transformation of kaolinite to halloysite10.1346/CCMN.1996.0440614 ↗
31. Functionalized SBA-15 materials as carriers for controlled drug delivery: influence of surface properties on matrix–drug interactions10.1021/la051167e ↗
32. Natural halloysite nanotubes as mesoporous carriers for the loading of ibuprofen10.1016/j.micromeso.2013.05.007 ↗
33. Clay nanotubes for encapsulation and sustained release of drugs10.1142/S1793292007000441 ↗
34. Organized shells on clay nanotubes for controlled release of macromolecules10.1002/marc.200800510 ↗
35. Halloysite clay nanotubes for resveratrol delivery to cancer cells10.1002/mabi.201200121 ↗
36. Conformational stability of ibuprofen: assessed by DFT calculations and optical vibrational spectroscopy10.1002/jps.21007 ↗
37. Interpretation of percent dissolved–time plots derived from in vitro testing of conventional tablets and capsules10.1002/jps.2600581021 ↗
38. Functionalization of halloysite clay nanotubes by grafting with γ-aminopropyltriethoxysilane10.1021/jp805657t ↗
39. Organosilane functionalization of halloysite nanotubes for enhanced loading and controlled release10.1088/0957-4484/23/37/375705 ↗
40. From platy kaolinite to aluminosilicate nanoroll via one-step delamination of kaolinite: effect of the temperature of intercalation10.1016/j.clay.2013.08.027 ↗
41. Adsorption behavior of methylene blue on halloysite nanotubes10.1016/j.micromeso.2007.10.018 ↗
42. Storage and release of ibuprofen drug molecules in hollow mesoporous silica spheres with modified pore surface10.1016/j.micromeso.2005.06.015 ↗